Grünenthal Group
Pernille Ritlov is an experienced professional with a robust background in pharmaceutical and medical marketing. Currently serving as Asset Lead and Nordic Country Manager at Grünenthal Group since February 2022, Pernille manages brand strategy and PnL for established brands in the UK, Ireland, and Nordic countries. Previously, as CEO of Noscomed Medical Supply A/S from March 2016 to April 2021, Pernille led a successful company turnaround and developed go-to-market strategies for new product launches. With earlier roles at Lundbeck and H. Lundbeck A/S, Pernille has extensive experience in global commercial strategy, market access, and brand management, including significant contributions to the development of pivotal mental health products. Academic credentials include a Master's in Business Strategy from Copenhagen Business School and an M.Sc. in Pharmacy from Danmarks Farmaceutiske Universitet.
This person is not in any teams
This person is not in any offices
Grünenthal Group
5 followers
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.